CA
TARO

Cetera Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Cetera Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$242K Buy
+5,716
New +$241K ﹤0.01% 2086

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Cetera Advisors's TARO Position: Q1 2024 in Review

Cetera Advisors opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024: 5,716 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #2086 among its holdings.

94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Cetera Advisors held 5,716 shares of Taro Pharmaceutical Industries Ltd. worth $242K as of Q1 2024.
  • Taro Pharmaceutical Industries Ltd. was a new Cetera Advisors position in Q1 2024.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2086 holding.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.